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Cerebral white matter lesion (WML) is one of the main causes for cognitive impairment
and is often caused by chronic cerebral hypoperfusion. A line of evidence has shown that
aspirin has neuroprotective effects and produces some benefits in long-term outcome and
survival for ischemic stroke patients. However, whether aspirin exerts a protective effect
against WML is still largely unknown. Here, we showed that aspirin could promote oligo-
dendrocyte precursor cell (OPC) proliferation and differentiation into oligodendrocytes after
WML. Male Sprague-Dawley rats were subjected to permanent bilateral common carotid
artery occlusion, a well-established model for WML. Four weeks later, Morris water maze
test showed an impairment of learning and memory ability of rat while aspirin treatment
improved behavioral performance. Low dose of aspirin (25 mg/kg) was found to elevate the
number of OPCs while relatively high doses (100–200 mg/kg) increased that of oligodendro-
cytes, and ameliorated WML-induced the thinning of myelin, as revealed by the electron
microscope. Similarly, our in vitro study also showed that relatively low and high doses
of aspirin enhanced OPC proliferation and differentiation into oligodendrocytes, respec-
tively. Furthermore, we revealed that aspirin enhanced extracellular signal-related kinase
(ERK) but inhibited RhoA activities. In summary, we provided the first evidence that aspirin
can promote oligodendrogenesis and oligodendrocyte myelination after WML, which may
involve ERK and RhoA pathways.
Keywords: aspirin, oligodendrocytes, oligodendrocyte precursor cells, white matter lesion, extracellular signal-
related kinase, RhoA
INTRODUCTION
Cerebral white matter lesions (WML) are observed in aging and
stroke and constitute the core pathology of Binswanger disease, a
form of subcortical vascular dementia (Shibata et al., 2004). These
WML are believed to be responsible for cognitive impairment and
are caused by chronic cerebral hypoperfusion (Pantoni and Gar-
cia, 1997). There is an evidence suggesting that the cerebral white
matter is as vulnerable to ischemia as cerebral gray matter (Pan-
toni et al., 1996). Dewar et al. (1999) emphasized that total brain
protection, in which not only gray matter but also white matter is
protected, is important and necessary.
However, damage to white matter, which is composed of myeli-
nated axons and oligodendrocytes, has been largely neglected.
Multiple mechanisms were involved in WML. For example,
maturation-dependent vulnerability in the oligodendrocyte lin-
eage was found in a hypoxic–ischemic injury model (Back et al.,
2002). Oligodendrocytes are best known as the myelin-forming
cells in the central nervous system (CNS). Oligodendrocyte pre-
cursor cells (OPCs) are immature oligodendrocytes and can dif-
ferentiate into myelin-forming cells under certain conditions (Fu
et al., 2005). In the adult brain, mature myelinating oligoden-
drocytes are continuously produced from local OPCs residing in
the brain parenchyma (Gensert and Goldman, 1997; Fancy et al.,
2004) and from precursor cells located in the subventricular zone
(Picard-Riera et al., 2002; Fancy et al., 2004; Menn et al., 2006).
Given their high migratory potential and their ability to differ-
entiate into myelin-forming cells, subventricular neural stem cells
(NSCs) represent an important endogenous source of OPCs for
preserving the oligodendrocyte population in the white matter
and for the repair of demyelinating injuries (Gonzalez-Perez and
Alvarez-Buylla, 2011). Therefore, it is proposed that any drug,
which can increase the number of OPCs and/or oligodendrocytes,
may be beneficial for the treatment of WML.
Aspirin has become a standard treatment for acute ischemic
stroke since it produces some benefit in long-term outcome and
survival if given within 14 days of stroke onset (Hankey et al.,
2003). Depending on its dosage, aspirin has a wide spectrum
of pharmacological activities and multiple sites of action, which
may contribute to the neuroprotection (Berger et al., 2004). So
far, numerous studies have shown the neuroprotective effects of
aspirin (Lorenzo Fernandez, 2002; Castillo et al., 2003; Vartiainen
et al., 2003; Berger et al., 2004; Asanuma et al., 2012). For exam-
ple, aspirin was found to be protective against ischemia-induced
neuronal damage in animal model (Castillo et al., 2003; Berger
et al., 2004) and in patients (Castillo et al., 2003), and against
dopamine quinone-induced neurotoxicity (Asanuma et al., 2012).
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Based on the evidence above, we proposed that aspirin might
exert a protective action against WML. Thus, in this study, using a
well-established WML model induced by chronic cerebral hypop-
erfusion, we examined the effects of different doses of aspirin on
rat learning and memory ability and the changes in the expres-
sion of oligodendrocyte lineage markers, and further explored
underlying mechanisms of aspirin.
MATERIALS AND METHODS
IN VIVO EXPERIMENTS
Animals and WML model
Adult male Sprague-Dawley (SD) rats (from the Fourth Mili-
tary Medical University Laboratory Animals Center, Xi’an, China),
weighing 250–300 g, were kept under standard housing conditions
at a temperature between 20 and 23°C, with a 12-h light–dark cycle
and a relative humidity of 50%. Rats were divided into three groups
randomly, the normal group, the control group, and the aspirin
group. Rats in the control and aspirin groups were undertaken with
WML model induced by permanent bilateral common carotid
artery occlusion, as described previously (Farkas et al., 2007). Dur-
ing the operation, the rat rectal temperature was monitored and
maintained at 37± 0.5°C. Immediately after cerebral ischemia, the
rats in aspirin group were received different doses (25, 50, 100, and
200 mg/kg, dissolved in 10% warm ethanol) of aspirin (Sigma-
Aldrich, St. Louis, MO, USA) daily for 4 weeks intraperitoneally,
and those in the control group were received the same volume of
ethanol. All experimental procedures were reviewed and approved
by the Animal Studies Committee of Fourth Military Medical Uni-
versity, Xi’an, China and animal study was carried out with the
established institutional guidelines regarding animal use and care.
Spatial learning and memory test
Morris water maze behavioral test was used to assess animal spa-
tial learning and memory abilities, as described previously (Morris,
1984). During the training trials, the platform location was fixed
and submerged under opaque water. Rats in each group (n= 5)
received four trials per day for four consecutive days. Each cycle
consisted of 90 s trials with 10 min in inter-trial interval. The time
to reach the platform was recorded every time. Once rats located
the platform, they were allowed to remain on it for 30 s. The rats
that failed to find the platform within 90 s were manually placed
on the platform for 30 s either. The rats that failed during four
consecutive days were excluded from the analysis because of the
possibility of a visual disturbance. For the assessment of spatial
memory retention, a 60-s probe trial was conducted at the end of
training, in which the platform was removed from the pool.
Anxiety-related behavior tests
Open field test was performed in a square arena (60 cm× 60 cm),
with a white floor divided into 36 squares (10 cm× 10 cm),
enclosed by continuous, 25 cm-high walls made of black plexi-
glass. The arena was lit by two red-light lamps (2× 60 W) placed
over its center. In this test, the 20 squares adjacent to the wall rep-
resent a protected field, named “arena periphery,” while the other
16 squares represent an exposed field, or “arena center.” The ani-
mals were routinely tested during the first half of the dark phase
of their light/dark cycle. The test was initiated by placing a single
rat in the middle of the arena and allowing it to move freely for
15 min. Rat behaviors were continuously monitored under a video
camera, and the total amount of time each rat spent in the arena
center was recorded.
Elevated plus test was performed, as described previously (Car-
ola et al., 2002). The test was initiated by placing a rat on the central
platform of the maze, facing one of the open arms, and allow-
ing it to move freely. Each session lasted 5 min and rat behavior
was monitored under a video camera placed above the apparatus.
Open-arm visits, closed-arm visits, and the total visits of rat were
recorded.
BrdU pulsing
For differentiation assays, the rats were received BrdU (100 mg/kg,
i.p. Sigma) once a day for 14 days after operation and then sacri-
ficed at 4 weeks for the observation of newly differentiated oligo-
dendrocytes. For proliferation assays, the rats were received three
pulses of BrdU (100 mg/kg) within 24 h before the animals were
sacrificed for the observation of proliferating OPCs.
Electron microscope
For electron microscopy, the tissues from epon-embedded cor-
pus callosum were trimmed and reoriented so that ultrathin cross
sections could be cut and treated with uranyl acetate and lead
citrate. Electron micrographs were analyzed using the analysis
DocuSystem (Soft Imaging System). At least 800 fibers from each
rat (n= 3 per treatment) were analyzed. According to a previous
study (Coetzee et al., 1996), axon diameter and fiber diameter
were measured (axon diameter was defined as the axon diameter
excluding myelin, in contrast to fiber diameter, which was defined
as axon diameter plus myelin) and G-ratios, which were defined as
the diameter of the axon divided by fiber diameter, were calculated.
IN VITRO EXPERIMENTS
Neural stem cell culture
Primary NSCs were isolated from the cerebral cortex of embryonic
day (E) 14.5 SD rats, as described previously (Chojnacki and Weiss,
2008). The cells grew as free-floating aggregates and were harvested
and mechanically dissociated to produce single cell suspension for
replating every 4–6 days. After a minimum of three passages, sin-
gle cell suspensions were plated on poly-l-lysine-coated (Sigma)
coverslips at a density of 5× 104 cells/coverslip, and maintained in
a differentiation medium [DMEM/F12 (Gibco/Invitrogen, Carls-
bad, CA, USA), 2% B27 (Gibco) and 1% fetal bovine serum (FBS,
HyClone, Logan, UT, USA)] with treatment of aspirin (0.1, 0.5, 1,
5, and 10µM) or same volume of ethanol for 4 or 7 days. After
fixed in 4% paraformaldehyde for 30 min, the cells were processed
for immunostaining, as described below.
OPC culture
Oligodendrocyte precursor cell culture and purification were per-
formed according to a previous study (Niu et al., 2012). For the
observation of OPC proliferation, 5× 104 cells were seeded on
coverslips and grew in modified OPC growth-medium (mOGM)
containing 15% of B-104CM, 1% N2 (Gibco) supplement, and
5µg/ml insulin (Sigma). For the observation of OPC differentia-
tion, OPCs on coverslips were cultured in mOGM containing 1%
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FBS. After OPCs were cultured for 1 day (for proliferation assay)
or 3 days (for differentiation assay) with the treatment of different
concentrations of aspirin (0.1, 0.5, 1.0, 5.0, and 10µM) and same
volume of ethanol, the cells were fixed in 4% paraformaldehyde
for 30 min and subjected to immunocytochemistry (see below).
For Western blot, the cells at a density of 2× 107 were cultured
in mOGM containing 1% FBS with 10µM aspirin for 3 days, and
then were harvested for Western blotting assay (see below).
RhoA activity detection
Cultured OPCs at a density of 1× 107 were maintained in mOGM
containing 1% FBS, supplemented with 10µM aspirin, 10µM
aspirin plus PD98059 [extracellular signal-related kinase (ERK)
inhibitor], and the same volume of ethanol, respectively. Then,
cell lysates of each group were collected and processed for West-
ern blot as previously described (Li et al., 2013b). The activity of
RhoA (Rho-GTP) was measured with the Rho Activation Assay Kit
(Cytoskeleton, Inc., Denver, CO, USA), according to the protocols
provided by the manufacture.
IMMUNOFLUORESCENCE STAINING
For brain tissues, the rats in different groups (n= 5) were sacri-
ficed and brains were cut into 30µm coronal floating sections
through the representative corpus callosum (from the bregma
1.20 to −5.04 mm) using a Leica CM1900 cryostat (Germany).
The sections were first incubated in 2 M HCl at 37°C for 30 min
and neutralized with 0.1 M borate buffer (pH 8.5) for 10 min.
For double immunofluorescence staining, floating sections were
incubated with rat anti-BrdU (1:300, Abcam, Cambridge, UK)
and mouse anti-NG2 (1:200, Millipore, Billerica, MA, USA) or
rabbit anti-proteolipid protein (PLP, 1:1000, Abcam) in PBS con-
taining 1% BSA and 0.3% Triton-X100 at 4°C overnight and
then incubated with anti-rat IgG conjugated with Cy3 (1:200,
Vector, Burlingame, CA, USA) or biotinylated anti-mouse/rabbit
IgG (1:300, Vector) for 2 h at room temperature. After wash-
ing, the sections were reacted with Cy2-conjugated streptavidin
(1:400; Jackson ImmunoResearch, West Grove, PA, USA) for 2 h at
room temperature and then observed under a FV-1000 confocal
microscope.
For cultured cells, the cells on the coverslips were incubated
with the following primary antibodies: mouse anti-A2B5 (1:200,
BD Pharmingen, Heidelberg, Germany), mouse anti-CNPase
(1:500, Abcam), rabbit anti-Ki67 (1:1000, Abcam), rabbit anti-
MBP (1:100,Abcam), and mouse anti-O4 (1:300, BD Pharmingen)
in PBS containing 1% BSA and 0.3% Triton-X100 at 4°C overnight:
after washing, the cells were incubated with anti-mouse/rabbit
IgG conjugated with Cy2 or Cy3 (1:300; Vector) for 1 h at room
temperature. The nuclei were stained with Hoechst 33342 (Sigma-
Aldrich) for 5 min. Immunostaining signals were observed under
a Leica DMIRB microscope.
WESTERN BLOT
Corpus callosum tissues and cultured cells were used for West-
ern blotting analysis, as detailedly described by our previous
study (Li et al., 2013b). Total proteins were extracted using a
compartment protein extraction kit (Millipore) according to the
manufacturer’s instructions. After electrophoresed on 10% SDS–
polyacrylamide gels, proteins in the gels were transferred onto
PVDF membranes (Millipore), which were incubated with fol-
lowing antibodies: anti-CNPase (1:1000, Abcam), anti-GAPDH
(1:3000, Kangwei Biotechnology, Shanghai, China), anti-MBP
(1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
anti-PDGFαR (1:500, Abcam). After extensive washing, the mem-
branes were incubated with horseradish peroxidase-conjugated
secondary antibody (1:10000, Kangwei Biotechnology) for 1 h at
room temperature and developed using an enhanced chemilumi-
nescence western blotting detection kit (Kangwei Biotechnology).
All band signals were quantified using ImageJ (NIH), and the
data acquired were normalized to GAPDH expression and further
normalized to the control.
QUANTIFICATION AND STATISTICAL ANALYSIS
For quantitation of PLP+,NG2+,BrdU+/PLP+, and BrdU+/NG2+
cells, the immunolabeled cells in the corpus callosum were counted
under the microscope at 400×magnification. The middle part of
corpus callosum bordered by the bilateral cingula was chosen for
counting. At least three to five independent brains were included
and six coronal sections (about 300µm apart) of each brain were
used for counting or analysis. The results were expressed as the
number of immunolabeled cells per square millimeter. For quan-
titation of cultured cells, positive cells were counted in a visual
field (about 1.0 cm2) at 200× and the results were expressed as a
percentage to the total cells indicated by Hoechst 33342 staining.
At least three to five independent experiments were performed for
each assay.
All data were presented as mean± SD and analyzed using SPSS
16.0 software. Differences between groups in behavior tests and
Western blot were assessed using one-way ANOVA followed by
Tukey’s post hoc test. Differences between aspirin groups and the
control in vitro were assessed using Student’s t -test. A probability
of p< 0.05 was considered statistically significant.
RESULTS
ASPIRIN IMPROVES ANIMAL LEARNING AND MEMORY ABILITY AFTER
WML
To examine the effects of aspirin on learning and memory ability
after WML in rats, Morris water maze was used to evaluate their
behavior performance. Our results showed that the escape laten-
cies in rats subjected to cerebral ischemia were significantly longer
than those in normal rats (Figures 1A,B). Though rats treated
with aspirin (25, 50, 100, and 200 mg/kg) were not different from
those treated with ethanol controls during the 1–3 days training
(Figure 1A), rats in aspirin groups took shorter time to find the
platform at 4 days after training (Figure 1B). No significant differ-
ence was observed among all doses of aspirin treatment group.
It was noted that there were no significant differences among
rats in the various groups in swimming speed throughout four
training days (Figure 1C). Additionally, it was reported that cogni-
tive impairment was often accompanied with depression (Richard
et al., 2013). To exclude possible effects of aspirin on anxiety and
depression in rats, we performed open field and elevated plus maze
tests. Our results showed that either the time spent in the arena
center in open field (Figure 1D) or the ratio of open-arm visits in
elevated plus maze test (Figure 1E), was not significantly differ-
ent between the aspirin and control groups. Taken together, our
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FIGURE 1 | Aspirin ameliorates cognitive impairment afterWML.
(A,B) Morris water maze was used for the evaluation of spatial learning in
rats after cerebral ischemia. (A) Effects of different concentrations of
aspirin on escape latency (time to find the hidden platform) plotted against
training day. (B) Escape latency recorded at fourth training day. There was
no significant difference among the aspirin groups, #p<0.05 vs. the
normal; *p<0.05 vs. the control. (C) Swimming speeds were not affected
among different groups. (D,E) Analysis of animal anxiety-like behavior.
Open field (C) and elevated plus maze (D) were used for the assessment
of anxiety-like behavior.
behavioral results indicate that aspirin can improve learning and
memory ability after WML.
ASPIRIN PROMOTES OPC PROLIFERATION AND DIFFERENTIATION
AFTER WML
To evaluate the effects of aspirin on oligodendroglia in the
WML animal brain, we examined the changes of oligoden-
drocyte lineage in corpus callosum at 4 weeks after cerebral
ischemia. Compared with the normal rats, the number of the
cells expressing PLP, a marker for mature oligodendrocyte, was
significantly decreased (Figures 2A,C,G) in the control rats sub-
jected to cerebral ischemia. However, aspirin treatment at doses
of 25–200 mg/kg attenuated ischemia-induced reduction of oligo-
dendrocytes (Figures 2C,E,G). Moreover, the number of NG2-
expressing OPCs were also increased after cerebral ischemia and
further elevated with treatment of 25 mg/kg aspirin whereas
50, 100, and 200 mg/kg of aspirin did not have this effect
(Figures 2B,D,F,H).
In order to investigate whether aspirin acts on the develop-
ment of oligodendrocyte lineage, we examined OPC proliferation
and differentiation by BrdU-pulse labeling assays. In the treat-
ment of 100 and 25 mg/kg aspirin, the number of PLP+/BrdU+
double-stained new-differentiated oligodendrocytes and that of
NG2+/BrdU+ double-labeled proliferating OPCs reached the
peak (Figures 2A–F,I,J), respectively. In addition, we isolated the
corpus callosum of each group and examined the protein lev-
els of PDGFαR (a marker for OPCs), CNPase (a marker for
pre-oligodendrocytes), and MBP (a marker for mature oligo-
dendrocytes) by Western blot. Immunoblotting results showed
that the expression of PDGFαR was upregulated after cerebral
ischemia and further enhanced by 25 mg/kg aspirin treatment,
which, however, was decreased by the treatment with 100 and
200 mg/kg aspirin (Figure 3A). By contrast, ischemia caused
downregulation of MBP expression whereas 25–200 mg/kg aspirin
ameliorated ischemia-induced decreased MBP expression. Noted
that the MBP expression levels in 100 mg/kg aspirin-treated rats
were higher than that in normal group (Figure 3B). Unexpect-
edly, aspirin did not affect CNPase expression (Figure 3C). Taken
together, these results suggest that low dose of aspirin (25 mg/kg)
may promote OPC proliferation while relatively high doses of
aspirin (100 mg/kg) may enhance OPC differentiation into mature
oligodendrocytes.
Furthermore, to investigate whether aspirin-induced increased
mature oligodendrocytes can affect the myelin thickness after
WML, we undertook an ultra-structural analysis of myelinated
axons in the white matter tract of corpus callosum at 4 or 6 weeks
after cerebral ischemia in rats with/without the treatment of
100 mg/kg aspirin. Compared with the normal, demyelination
and reduction of myelin thickness were evident in the control
rats subjected to ischemia (Figures 3D,E). Four-or six-week treat-
ment of aspirin attenuated ischemia-induced demyelination and
reduction of myelin thickness (Figures 3F,G). For quantitation,
we assessed G-ratio, the ratio of axonal diameter to fiber diame-
ter, which revealed an attenuated G-ratio in aspirin-treated rats,
compared with the control (Figure 3H), suggesting a recov-
ery in the average myelin thickness with aspirin treatment. It
was noted that the effect of 6-week treatment of aspirin was
seemingly better than that of 4-week treatment though with
no significant difference (Figures 3F–H). Overall, our results
demonstrate that depending on its dosage, aspirin may pro-
tect against ischemia-induced WML by affecting OPC fate and
oligodendrocyte myelination.
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FIGURE 2 | Aspirin increases the numbers of oligodendrocytes and
OPCs afterWML. (A–F) Representative immunostaining micrographs
showing oligodendrocytes and OPCs. Coronal sections across corpus
callosum (as indicated in the left lower schematic) from the normal
(A,B), control (C,D), and aspirin-treated (E,F) rats were double-stained
with BrdU (red) and PLP [green; (A,C,E)] or NG2 [green; (B,D,F)]. Insets
show higher magnification of the cells boxed in respective panels. Scale
bars: 100µm (A–F), 25µm (insets). ac, Anterior commissure; cc, corpus
callosum; Cx, cortex; CPU, caudate putamen; Lv, lateral ventricle.
(G–J) Quantitation of the numbers of PLP+ (G), NG2+ (H), PLP+/BrdU+
(I), and NG2+/BrdU+ (J) cells in each group. Note that low dose of aspirin
(25 mg/kg) increased NG2-expressing cells while relatively high doses of
aspirin (100–200 mg/kg) increased PLP-expressing cells, #p<0.05 vs. the
normal; *p<0.05 vs. the control.
ASPIRIN PROMOTES OPC PROLIFERATION AND DIFFERENTIATION
IN VITRO
In order to confirm the effects of aspirin in vitro, we treated
cultured OPCs with different concentrations of aspirin. Double
staining of A2B5 (a marker for OPCs) and Ki67 (a marker for
proliferating cells) was used for the observation of OPC prolifer-
ation. Our results showed that compared with the controls, more
A2B5+/Ki67+ cells were present with the treatment of 0.1µM
aspirin whereas fewer were observed with the treatment of 10µM
(Figures 4A–C,G). After OPCs were cultured in differentiation
medium for 3 days, CNPase immunostaining was used for the
evaluation of OPC differentiation. In the presence of 1.0–10µM
aspirin, more CNPase+ cells were observed than the controls while
0.1–0.5µM did not have this effect (Figures 4D–F,H). Therefore,
these in vitro data suggest that relatively low concentrations of
aspirin could promote OPC proliferation while relatively high
concentrations promote their differentiation.
ASPIRIN PROMOTES NSC DIFFERENTIATION INTO OPCs AND
OLIGODENDROCYTES IN VITRO
Since NSCs are an important endogenous source of OPCs and
sequential oligodendrocytes (Gonzalez-Perez and Alvarez-Buylla,
2011), we next investigated whether aspirin could affect the differ-
entiation of NSCs into OPCs and oligodendrocytes. NSCs cultured
in a differentiation medium for 4 and 7 days were immunos-
tained with OPC marker O4 and oligodendrocyte markers CNPase
or MBP, respectively. Compared with ethanol control, aspirin
with different concentrations (0.1–10µM) increased the num-
ber of O4+ cells (Figures 5A,B,G). Differently, only relatively
high concentrations of aspirin (5.0–10µM) increased the num-
ber of CNPase+ or MBP+ cells, as compared to the controls
(Figures 5C–F,H,I). Importantly, we found that increased number
of CNPase+ or MBP+ cells companied with decreased number of
GFAP+ cells (data not shown), indicating that the promotive effect
of aspirin on NSCs differentiation into oligodendrocytes may be
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FIGURE 3 | Aspirin promotes the expression of oligodendrocyte proteins
and myelin thickness afterWML. (A–C)Western blotting analysis of OPC
protein PDGFαR (A), myelin protein MBP (B), and pre-oligodendrocytes
protein CNPase (C) from corpus callosum lysates of the normal, control, and
aspirin-treated rats. Note that the maximum expression levels of PDGFαR and
MBP were observed in the treatment of 25 and 100 mg/kg aspirin,
respectively. GAPDH was used as an internal control, #p<0.05 vs. the
normal; *p<0.05 vs. the control. (D–G) Representative electron microscopy
micrographs (40,000×) of corpus callosum from the normal (D), control
(E), 100 mg/kg aspirin-treated group at 4 weeks (F), or 6 weeks
(G). Arrowheads indicate demyelination and asterisks show the thinning
myelin. Scale bar: 0.5µm. (H) Graphical representation of the G-ratio of
individual fibers in relation to axon diameter (presented as scatter plots) at
6 weeks. Straight lines represent the linear regression line for each dataset.
at the expense of astrocytes. These results imply that aspirin can
promote the differentiation of NSCs into OPCs and sequential
oligodendrocytes.
ASPIRIN ENHANCES ERK AND INHIBITS RhoA ACTIVITIES
A line of evidence has shown that p21Ras/MAPK (ERK) and
Rho signaling pathways play crucial roles in oligodendroglial
development (Stariha et al., 1997; Liang et al., 2004; Younes-
Rapozo et al., 2009; Chew et al., 2010; Fyffe-Maricich et al.,
2011; Zhao et al., 2013). Thus, to investigate the underlying
mechanism(s) of aspirin, we first examined its effect on ERK1/2
pathway in OPCs cultured in a differentiation medium. Ten
micromolar aspirin significantly upregulated MBP expression and
enhanced ERK1/2 activity as revealed by increased phosphor-
ERK expression, compared with ethanol control. However, addi-
tion of ERK inhibitor PD98059 (specific ERK kinase inhibitor;
Tocris Cookson) either reversed the upregulated MBP expres-
sion and the enhanced ERK1/2 activity (Figures 6A,B). In addi-
tion, treatment of OPCs with aspirin reduced the activity of
RhoA (approximate 80%), compared with the control group
(Figures 6C,D). Thus, these results indicate that aspirin may pro-
mote oligodendrogenesis via enhancing ERK and inhibiting RhoA
activities.
DISCUSSION
In the present study, we provided the first evidence that aspirin
could protect against WML-induced impairment of learning and
memory ability and promote OPC proliferation and differentia-
tion. This promotive effect of aspirin may involve its ability to
enhance ERK and inhibit RhoA activities.
It is known that depression is always accompanied with cogni-
tive impairment (Richard et al., 2013). In a previous study, some
NSAIDS such as aspirin or drugs like simvastatin that have an anti-
inflammatory action could be useful in some depressive patients
(Rahola, 2012). Furthermore, it was shown that aspirin could
decrease the risk of depression in older men with high plasma
homocysteine (Almeida et al., 2012). Thus, to confirm the benefi-
cial effect of aspirin on impairment of learning and memory ability
rather than depression after cerebral ischemia in the present study,
we preformed open field and elevated plus maze test, and found
that aspirin had no significant effects on anxiety and depression
in rats.
Numerous clinical studies have shown that aspirin is widely
used for stroke prevention. Depending on its dosage, aspirin has a
wide spectrum of pharmacological activities and multiple sites of
action. For example, its secondary preventive effects after ischemic
events have been generally attributed to its antiplatelet actions
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FIGURE 4 | Aspirin promotes OPC proliferation and differentiation
in vitro. (A–F) Representative immunostaining micrographs showing
OPC differentiation. Cultured OPCs treated with ethanol (control) or
different concentrations of aspirin were double-stained with Ki67 (red)
and A2B5 [green; (A–C)] or single-stained with CNPase [green; (D–F)].
Nuclei were counterstained with Hoechst 33342. Insets show higher
magnification of the cells boxed in respective panels. Scale bars: 50µm
(A–F), 25µm (insets). (G,H) Quantitation of the percentage of
Ki67+/A2B5+ (G) and CNPase+ (H) cells to total cells in each group,
*p<0.05 vs. the control.
through the inhibition of cyclooxygenase, which is already reached
at low doses (as low as 20–40 mg/day) (Group, 1991; van Gijn,
1992). Moreover, aspirin exerts antipyretic and analgesic effects at
medium doses (about 2–4 g/day) and anti-inflammatory effects at
high doses (6–8 g/day) in humans (Fitzgerald, 2004). It is widely
acknowledged that in humans the metabolism of many drugs may
vary considerably from rodents, and therefore must be adjusted
for application in rodents. Therefore, according to an equa-
tion: dose (rat)/dose (human)=BW−0.25 (rat)/BW−0.25 (human)
(BW= body weight), which scales human doses to rats (Hau,
2003), we chose 25 mg/kg (relatively low dose), 100–200 mg/kg
(relatively high dose) for aspirin treatment in the present study.
Application of these doses of aspirin, interestingly we found
in vivo and in vitro that aspirin can promote OPC prolifera-
tion at a relatively low dose while enhance their differentiation
into oligodendrocytes and myelination at a relatively high dose
(Figures 2–4). We observed that low dose of aspirin can upreg-
ulate the expression of OPC markers (e.g., NG2 and PDGFαR)
but meantime suppress that of mature oligodendrocyte markers
(e.g., PLP and MBP). By contrast, high dose of aspirin had just
the opposite effects. We proposed that more OPCs were under-
going proliferation in the treatment of low dose rather that high
dose of aspirin and vice versa. Additionally, we found that aspirin
seemingly had little effect on the expression of pre-mature oligo-
dendrocytes (CNPase), and this may reflect a balance state of
oligodendrocyte lineage. In addition, cell loss or dysfunction has
been shown to be responsible for animal behavior deficits. It
was reported that hippocampal cell loss was possibly related to
memory dysfunction (Smith et al., 1991). Loss of oligodendro-
cytes and of myelin was involved in vascular dementia patients
after hypoxic–ischemic damage (Ihara et al., 2010), whereas oligo-
dendrocyte remyelination was strongly correlated with the recov-
ery of cognitive dysfunction following chronic cerebral ischemia
(Chida et al., 2011). In the present study, aspirin could attenuated
ischemia-induced demyelination and reduction of myelin thick-
ness (Figure 2), probably accounting for the beneficial effects of
aspirin on cognitive dysfunction.
In addition to local origin, OPCs are also arise from sub-
ventricular NSCs, an important endogenous source for preserv-
ing oligodendrocytes in the white matter and for the repair of
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FIGURE 5 | Aspirin promotes NSC differentiation into OPCs and
sequential oligodendrocytes. (A–F) Representative immunostaining
micrographs showing NSC differentiation. Cultured NSCs treated with ethanol
(control) or different concentrations of aspirin were immunostained with O4
(A,B), CNPase (C,D), or MBP (E,F). Nuclei were counterstained with Hoechst
33342. Scale bar: 50µm. (G–I) Quantitation of the percentage of O4+
(G), CNPase+ (H), or MBP+ (I) cells to all cells in each group. Note that
although aspirin at different concentrations increased O4-expressing cells
while only relatively high concentrations of aspirin (5–10µM) increased
CNPase- or MBP-expressing cells, *p<0.05 vs. the control.
demyelinating injuries. Although under normal conditions, the
production of oligodendrocytes in the SVZ is scarce (Menn et al.,
2006), demyelinating lesions in the neighboring white matter can
significantly increase the generation of OPCs from SVZ progeni-
tors (Nait-Oumesmar et al., 1999; Picard-Riera et al., 2002; Menn
et al., 2006), which may also account for cerebral ischemia-induced
upregulated expression of OPC markers (NG2 and PDGFαR) in
the present study (Figures 2 and 3). Importantly, our in vitro
data showed that aspirin could promote the differentiation of cul-
tured NSCs into OPCs and sequential oligodendrocytes (Figure 5),
indicating a possible beneficial function of aspirin in mobilizing
endogenous NSCs against WML.
A group of studies have demonstrated that the effectiveness of
aspirin in stroke treatment depends on various pathways beyond
its antiplatelet and anti-inflammatory functions. Low dose aspirin
was reported to inhibit the activity of RhoA (Li et al., 2013a), one
of well-known members of the Rho GTPase family that regulates
a wide range of fundamental cell functions such as proliferation
and apoptosis. RhoA inactivation was found to enhance the prolif-
eration of hematopoietic stem and progenitor cells (Ghiaur et al.,
2006) and the differentiation and myelination in oligodendrocytes
(Zhao et al., 2013). In addition, ERK pathways have particularly
well-documented roles in proliferation and differentiation for var-
ious stem and precursor cells (Burdon et al., 2002). Constitutive
activation of Erk1/2 signaling in oligodendrocytes not only caused
myelination to occur earlier but also significantly induced more
oligodendrocytes to myelinated in vitro (Xiao et al., 2012). Con-
sistently, our in vitro results showed that aspirin could enhance
ERK but inhibit RhoA activities (Figure 6), indicating aspirin-
mediated ERK activation and RhoA inhibition may be involved
in OPC proliferation and differentiation. Intriguingly, a group
of studies had shown that aspirin exerted an inhibitory effect
on ERK activity in neuronal protection or apoptosis induction
of carcinoma cells (Tegeder et al., 2001; Vartiainen et al., 2003;
Park et al., 2010; Im and Jang, 2012). It is likely that this dis-
crepancy of aspirin effectiveness may depend on different cell
types and injury models used since these studies mainly focused
on the effects of ERK on apoptosis during inflammation and
tumorigenesis. By contrast, our study engaged in the effects of
ERK on proliferation and differentiation during oligodendrocyte
development.
In summary, we provide the first evidence that aspirin can pro-
mote OPC proliferation and differentiation and oligodendrocyte
myelination after chronic cerebral ischemia by at least activat-
ing ERK and inhibiting RhoA activities. This promotive effect of
aspirin on oligodendrocyte lineage may account for the recovery of
ischemia-induced cognition impairment, suggesting a promising
role of aspirin in the treatment of WML.
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FIGURE 6 | Aspirin enhances ERK but inhibits RhoA activities.
(A)Western blot analysis of MBP, phospho-ERK1/2, and total-ERK1/2
protein levels from cultured OPCs treated with ethanol, 10µM aspirin,
or 10µM aspirin plus ERK1/2 inhibitor PD98059. Note that aspirin can
enhance ERK activity as revealed by phospho-ERK1/2 protein level.
GAPDH was used as an internal control. (B) Quantitation of MBP, and
phospho-ERK1/2 levels in each group, *p<0.05 vs. the control;
#p<0.05 vs. aspirin treatment group. (C,D) RhoA activity assay.
Aspirin inhibited RhoA activity by approximate 80%, *p<0.05 vs. the
control.
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